Companies: 10,795·Total market cap: $144.5T
Cellyan Biotechnology Co., Ltd

Cellyan Biotechnology Co., Ltd

HKPDNASDAQHealthcare● Active
$0.50
+$0.01(+1.03%)
Market Cap$5488579
P/E Ratio
52W High$2.58
52W Low$0.37

Cellyan Biotechnology Co., Ltd (HKPD) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

hkpd · pe ratio · data through Mar 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Cellyan Biotechnology Co., Ltd (HKPD) measures how much investors pay for each dollar of the company's trailing earnings. HKPD's current PE ratio of N/A is calculated by dividing its stock price of $0.50 by its TTM earnings per share of -$0.00.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-03-31

Forward P/E
N/A
EPS (TTM)
-$0.00
TTM · diluted EPS
PEG Ratio
-1.60
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Cellyan Biotechnology Co., Ltd SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-08

PE Ratio History

2023 – 2025 · Annual
PE Ratio (TTM)
5Y Avg 23.4x
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Pharmaceuticals · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Cellyan Biotechnology Co., Ltd
Cellyan Biotechnology Co., LtdYou
HKPD
$5MN/A-$0.00
Art's-Way Manufacturing Co., Inc.
Art's-Way Manufacturing Co., Inc.
ARTW
$14M10.92x$0.20
Addentax Group Corp.
Addentax Group Corp.
ATXG
$3MN/A-$12.75
Freightos Limited Ordinary shares
Freightos Limited Ordinary shares
CRGO
$87MN/A-$0.35
Jayud Global Logistics Limited
Jayud Global Logistics Limited
JYD
$2MN/A-$2.17
Lakeside Holding Limited
Lakeside Holding Limited
LSH
$5MN/A-$0.69
New Century Logistics (BVI) Limited
New Century Logistics (BVI) Limited
NCEW
$54MN/A-$0.48

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 3 of 3 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-03-31Latest
FY2025
$-0.00
2024-03-31
FY2024
15.62x$0.18-49.7%
2023-03-31
FY2023
31.08x$0.09

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Cellyan Biotechnology Co., Ltd (HKPD) measures how much investors pay for each dollar of the company's trailing earnings. HKPD's current PE ratio of N/A is calculated by dividing its stock price of $0.50 by its TTM earnings per share of -$0.00.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.50 ÷ -$0.00 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

HKPD pe ratio · 6 questions

HKPD's current PE ratio is N/A as of 2026-06-08, based on a stock price of $0.50 and TTM EPS of -$0.00. Data sourced from Financial Modeling Prep via HKPD's SEC 10-K and 10-Q filings.

HKPD PE ratioWhat is HKPD PE ratioCurrent PE ratio of HKPDHKPD PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Cellyan Biotechnology Co., Ltd SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08